scispace - formally typeset
S

Sina Bavari

Researcher at United States Army Medical Research Institute of Infectious Diseases

Publications -  353
Citations -  21495

Sina Bavari is an academic researcher from United States Army Medical Research Institute of Infectious Diseases. The author has contributed to research in topics: Ebola virus & Virus. The author has an hindex of 69, co-authored 349 publications receiving 18782 citations. Previous affiliations of Sina Bavari include University of Nebraska Medical Center & Walter Reed Army Institute of Research.

Papers
More filters
Journal ArticleDOI

Functional CD8+ T Cell Responses in Lethal Ebola Virus Infection

TL;DR: A functional and specific, albeit insufficient, adaptive immune response is made in lethal EBOV infection and is protective upon transfer to naive infected recipients, which should cause a change in the current view of the ‘impaired’ immune response to E BOV challenge and may help spark new therapeutic strategies to control lethal filovirus disease.
Journal ArticleDOI

Identification of an antioxidant small-molecule with broad-spectrum antiviral activity

TL;DR: Small molecule chemical screening for Ebola virus inhibitors resulted in identification of a compound NSC 62914, which was found to exhibit anti-filovirus activity in cell-based assays and in vivo protected mice following challenge with Ebola or Marburg viruses.
Journal ArticleDOI

Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A.

TL;DR: These results, combined with an understanding of the molecular nature of superantigen and receptor interactions, indicate that targeting MHC class II binding by site-directed mutagenesis will produce the most effective vaccine.
Journal ArticleDOI

Association of ebola virus matrix protein VP40 with microtubules.

TL;DR: It is reported that Ebola virus associates with microtubules via the matrix protein VP40, and an in vitro polymerization assay demonstrated that VP40 directly enhances tubulin polymerization without any cellular mediators.
Journal ArticleDOI

Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.

TL;DR: Results show that vaccination with the ZEBOVGP-Fc fusion protein alone without the need of a viral vector or assembly into virus-like particles is sufficient to induce protective immunity against ZE BOV in mice.